Jun 28, 2024
- Corporate
Announcement of a Director Resignation
TOKYO, June 28, 2024 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that a Director will resign on June 30, 2024. Details are as follows.
- Resigning Director: Director, James H. Sabry
- Effective date: June 30, 2024
- Reason of resignation: Due to his personal reasons
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Hideki Sato
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Takayuki Sakurai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
